1-1 of 1
Silvia C. Ling, MBBS, FRACP, FRCPA
Close
Sort by
Journal Articles

XBP-1 Levels Predict Sensitivity of Myelomas to Proteasome Inhibitor Bortezomib.

Silvia C. Ling, MBBS, FRACP, FRCPA, Edwin Lau, BSc, Lye L. Ho, MBBS, FRCPA, FRACP, Joy Ho, MBBS, FRCPA, FRACP, Douglas E. Joshua, MBBS, DPHil(Oxon)FR, John Allen, PhD
Journal: Blood
Blood (2007) 110 (11): 1473.
https://doi.org/10.1182/blood.V110.11.1473.1473
Published: 2007